By Matthew Holt Saturday's New York Times portends more trouble for big Pharma. The headline is wrapped up in an examination of foreign corrupt practices, but the bigger issue is that clinical trials have hidden serious adverse events. The recent
Read More...
Read the complete post at http://www.thehealthcareblog.com/the_health_care_blog/2010/08/can-health-20-fix-clinical-trials.html
Posted
Aug 16 2010, 03:53 AM
by
The Health Care Blog